CHOLESTEROL LOWERING IN THE ELDERLY
CHOLESTEROL LOWERING IN THE ELDERLY
批准号:
3553431
负责人:
JOHN C LAROSA
金额:
$26.78万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 1992-06-30
关键词:
HMG coA reductases antihypercholesterolemic agent antihyperlipoproteinemic agent blood chemistry clinical trials health care cost /financing human old age (65+) human subject human therapy evaluation hypercholesterolemia low density lipoprotein medical outreach /case finding myocardial infarction nutrition education nutrition related tag oxidoreductase inhibitor therapy compliance
中文摘要
美国人口老龄化将对医疗保健产生长期影响
在美国交货。 到2000年,美国人口普查局
预计65岁以上的人口将达到3 500万,
到2050年,将近七千万人 老年人最致残的医疗问题
美国人是心血管疾病,目前影响超过3.6
数百万美国老年人 血清胆固醇升高,主要风险
在65-75岁的人群中,30%的男性和40%的女性患有心脏病。
虽然降低胆固醇已被证明可以降低心血管风险,
年龄在60岁以下的人,没有在60-75岁的人中进行过研究
岁的 洛伐他汀的出现,其易于使用,低水平的
副作用,和强大的能力,降低低密度脂蛋白,现在这样的研究,
降低胆固醇可能在老年人。 所附提案
概述了一项双盲,随机试点研究,
开展合作的长期临床试验的可行性
对未来医疗保健的积极影响。 如果
发现降低胆固醇可降低老年人的心血管风险,
数以百万计的美国老年人可以治疗高胆固醇,
过早死亡和残疾。 如果降低胆固醇不能减少
心血管疾病发病率和死亡率,数百万美国老年人和
国家的医疗保健预算将免除不便和费用
治疗是没有好处的。 鉴于国家的老龄化,
这些发现将对未来产生深远的影响。
英文摘要
The aging of the U.S. population will have long term effects on health care
delivery in the United States. By the year 2000, the U.S. Bureau of Census
projects that the number of persons over age 65 will reach 35 million and
by 2050, nearly 70 million. the most disabling medical problem in older
Americans is cardiovascular disease which currently affects more than 3.6
millions older Americans. Elevated serum cholesterol, a primary risk
factor for heart disease, occurs in 30% of men and 40% of women aged 65-75.
While cholesterol lowering has been shown to reduce cardiovascular risk in
individuals under age 60, no studies have been done in individuals 60-75
years of age. The advent of lovastatin, with its ease of use, low level of
side effects, and powerful ability to lower LDL, now makes such a study of
cholesterol lowering possible in the elderly. The enclosed proposal
outlines a double-blind, randomized pilot study which will test the
feasibility of conducting a collaborative, long term, clinical trial of the
effects of aggressive implications for health care in the future. If
cholesterol lowering is found to reduce cardiovascular risk in the elderly,
millions of older Americans can be treated for high cholesterol and spared
premature death and disability. If cholesterol lowering does not reduce
cardiovascular morbidity and mortality, millions of older Americans and the
health care budget of the nation will be spared the inconvenience and costs
of treatment which is not beneficial. Given the aging of the nation, such
findings will have profound implications for the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NATIONAL INSTITUTE ON AGING (NIA): AGING COLONY MAINTENANCE
-
批准号:6288137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1999
-
负责人:JOHN C LAROSA
-
依托单位:
MINORITY HIGH SCHOOL STUDENT RESEARCH APPRENTICE PROGRAM
-
批准号:3512965
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1990
-
负责人:JOHN C LAROSA
-
依托单位:
CHOLESTEROL LOWERING IN THE ELDERLY
-
批准号:3553430
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1990
-
负责人:JOHN C LAROSA
-
依托单位:
MINORITY HIGH SCHOOL STUDENT RESEARCH APPRENTICE PROGRAM
-
批准号:2282715
-
项目类别:
-
资助金额:$1.3万
-
财政年份:1990
-
负责人:JOHN C LAROSA
-
依托单位:
MINORITY HIGH SCHOOL STUDENT RESEARCH APPRENTICE PROGRAM
-
批准号:3512964
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1990
-
负责人:JOHN C LAROSA
-
依托单位:
CHOLESTEROL LOWERING IN THE ELDERLY
-
批准号:3553432
-
项目类别:
-
资助金额:$13.96万
-
财政年份:1990
-
负责人:JOHN C LAROSA
-
依托单位:
POSTMENOPAUSAL HORMONE THERAPY--RISKS AND BENEFITS
-
批准号:3553203
-
项目类别:
-
资助金额:$9.94万
-
财政年份:1987
-
负责人:JOHN C LAROSA
-
依托单位:
POSTMENOPAUSAL HORMONE THERAPY--RISKS AND BENEFITS
-
批准号:3553205
-
项目类别:
-
资助金额:$30.62万
-
财政年份:1987
-
负责人:JOHN C LAROSA
-
依托单位:
POSTMENOPAUSAL HORMONE THERAPY--RISKS AND BENEFITS
-
批准号:3553206
-
项目类别:
-
资助金额:$24.26万
-
财政年份:1987
-
负责人:JOHN C LAROSA
-
依托单位:
POSTMENOPAUSAL HORMONE THERAPY--RISKS AND BENEFITS
-
批准号:3553207
-
项目类别:
-
资助金额:$30.21万
-
财政年份:1987
-
负责人:JOHN C LAROSA
-
依托单位:
METABOLIC EFFECTS OF HORMONE REPLACEMENT/POST-MENOPAUSE
-
批准号:3115075
-
项目类别:
-
资助金额:$7.83万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
PREVENTIVE CARDIOLOGY ACADEMIC AWARD NHBLBI
-
批准号:3077035
-
项目类别:
-
资助金额:$10.66万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
MENOPAUSAL HORMONE THERAPY AND ATHEROSCLEROTIC RISK
-
批准号:3348449
-
项目类别:
-
资助金额:$23.67万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
METABOLIC EFFECTS OF HORMONE REPLACEMENT/POST-MENOPAUSE
-
批准号:3115074
-
项目类别:
-
资助金额:$42.23万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
METABOLIC EFFECTS OF HORMONE REPLACEMENT/POST-MENOPAUSE
-
批准号:3115077
-
项目类别:
-
资助金额:$52.58万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
MENOPAUSAL HORMONE THERAPY AND ATHEROSCLEROTIC RISK
-
批准号:3348448
-
项目类别:
-
资助金额:$23.62万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
METABOLIC EFFECTS OF HORMONE REPLACEMENT/POST-MENOPAUSE
-
批准号:3115076
-
项目类别:
-
资助金额:$45.13万
-
财政年份:1985
-
负责人:JOHN C LAROSA
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3514570
-
项目类别:
-
资助金额:$5.82万
-
财政年份:1979
-
负责人:JOHN C LAROSA
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3514569
-
项目类别:
-
资助金额:$12.2万
-
财政年份:1979
-
负责人:JOHN C LAROSA
-
依托单位:
REGIONAL PRIMATE RESEARCH CENTER
-
批准号:2281174
-
项目类别:
-
资助金额:$509.02万
-
财政年份:1978
-
负责人:JOHN C LAROSA
-
依托单位: